Approche pour l'identification des causes de la mauvaise décantation des solides biologiques

Les procédés d'épuration biologique à culture libre (boues activées) comprennent habituellement un décanteur qui permet de concentrer les solides biologiques en vue de leur recirculation en tête du réacteur biologique. Lorsque ce décanteur fonctionne mal on observe une perte de solides biologiques (SB), ce qui se traduit par une augmentation de la concentration des matières en suspension (MES) dans l'effluent du décanteur secondaire et par une baisse des performances du procédé d'épuration. Lorsque la concentration de MES dans l'effluent du décanteur secondaire est trop élevée on mesure l'indice de volume des boues (IVB). Un IVB faible indique que les solides biologiques ont de bonnes caractéristiques de décantation de sorte que la cause de la mauvaise efficacité du décanteur est d'ordre physique et peut être identifiée facilement. Lorsque l'IVB est élevé, la mauvaise décantation est alors causée par un désordre de l'écosystème qui se traduit le plus souvent par une croissance excessive d'organismes filamenteux. Les causes et les solutions d'un tel problème sont alors difficiles à identifier. Pour ce travail, les auteurs ont réalisé une importante revue bibliographique dont les résultats sont présentés sous la forme d'un cheminement critique (fig. 1). Dans cette figure, les cases numérotées de 1 à 48 sont liées par des énoncés logiques. Ainsi, en répondant à des questions simples, il est possible de cheminer dans la figure 1 et d'identifier les causes les plus probables du déséquilibre microbiologique ainsi que les solutions qui ont déjà été apportées avec succès. De plus les auteurs ont associé à chaque case une fiche technique (portant le même numéro que la case) sur laquelle sont présentées des explications et la liste des références consultées.Activated sludge is a microbiological aerated sewage treatment process which includes a secondary clarifier to separate the treated effluent from the biological solids. Part of the concentrated solids is recirculated to maintain an adequate concentration of mixed liquor suspended solids (MLSS) In the aerated basin. When the secondary clarifier malfunctions, some biological solids are lost to the effluent : the process efficiency drops and the concentration of suspended solids (SS) increases. When the SS in the effluent is too high the sludge volume index (SVI) must be measured. A low SVI means that the biological solids have good sedimentation characteristics : the problem is thon physical in nature and is easily identified. When the SVI is high, the problem is due to a disturbance of the microbiological ecosystem, which is at the origin of excessive filamentous organism growth. The origins and solutions of such a problem are much harder to find. To this end the authors proceeded with an important review of the literature, the results of which are summarized through a critical path, in figure 1. Files from 1 to 48 are linked by logical statements in such a way that by answering simple questions, one can proceed through the files and identify the must probable cause of the biological disturbance as well as the solution which has already proven successful. Furthermore, the authors have linked each file to a technical file which bears the same number and on which an explanation and references are found.Before proceeding with figure 1 to identify a problem in real life, one must obtain information, resulting from an analysis and observations, with regard to plant effluent, primary clarifier effluent and activated sludge characteristics, including the MLSS concentration. One must also know the chemical oxygen demand (COD), the soluble and total biochemical oxygen demand (BOD5), as well as the nitrogen and phosphorus concentrations in the plant influent. Furthermore, one must also be told of the presence of toxic material or industrial wastes in the sewage and of the fraction of pollution load which is in the form of particulates. Whether sudden changes in the quality of the plant influent have occurred is worth knowing. The concentration of oxygen or hydrogen sulfide in the primary clarifier is also important. One must also gather data related to the activated sludge treatment itself : type of reactor (completely mixed or plug flow), mixed liquor volatile suspended solids (MLVSS) concentration, dissolved oxygen concentration, rate of oxygen uptake and pH. Finally, the results of a microbiological analysis of the sludge are very useful.To illustrate the use of figure 1, let us say that we have the following data :a) Many filamentous microorganisms are present in the MLSS, in particular Microthrix parvicella, type 0092, and Thiothrix sp;b) The rate of dissolved oxygen uptake is 12 mg O2/g of SS - h;c) The rate of COD removal is 0,48 Kg/Kg of SS -d;d) There are no toxic substances in the plant influent;e) There are no abrupt changes in plant influent quality;f) The pHs of the plant influent and of the MLSS are 7,0 and 6,8 respectively;g) The ammonia nitrogen concentration of the plant influent is 1,2 mg/L (N);h) The phosphorus concentration of the plant influent is 4,4 mg/L (P);i) The total and soluble BOD5 concentrations of the plant influent are 400 and 80 mg/L respectively.With this information, we are ready to proceed through figure 1. From file one, one goes to file 2, since the rate of oxygen uptake is sufficient. Otherwise, we would have proceeded to file 32. The reactor being completely mixed, the next step is file 3, where it is said that, because of the low soluble BOD5 concentration one must go to file 9, where we find a fast of filamentous microarganisms which may be responsible for the disturbance. Since two of these microorganisms are effectively present in the mixed liquor suspended solids (MLSS), Microthrox parvicella and type 0092, we are invited to go to file 35, where it is stated that someone has already solved a similar problem by creating a modified contact zone to increase the substrats (organic matter) concentration around the microbiological flocs. The third filamentous microorganism is not identified in file 9. As a second possibility one may assume, in file 2. That the mixing is not complete, which is often the case. With the help of information and results of analyses already available, we proceed, through file 4, 14, 15 and 16, to file 20 where Thiothrixsp is included in the microorganisms listed. File 20 is linked to file 41, where it is said that the controlled addition of nitrogen in the plant influent has already been used to solve this type of problem.The critical path presented in this article is the result of an elaborate study. It may be used as a tool to identify the causes of bad biological flocs sedimentation in the secondary clarifier and select solutions that have already been used successfully

Decision-Making Measured by the Iowa Gambling Task in Patients with Alcohol Use Disorders Choosing Harm Reduction versus Relapse Prevention Program

AIMS: Two main therapeutic programs were offered to patients suffering from alcohol use disorders (AUDs): avoid the alcohol by abstinence or controlling their consumption. After information and motivational sessions, the patient chooses his own therapeutic plan. However, patients with AUD exhibit poor decision-making. The purpose of this study was to investigate the decision-making in AUD by comparing patients who chose to reduce and control their consumption to those who chose abstinence program. METHODS: Sixty-seven subjects with alcohol use disorder were included (AUD group) for treatment, choosing either a relapse prevention program (RPP) or a harm reduction program (HRP). Patients were compared to a healthy control group (n = 31). Cognitive skills were assessed through the Montreal Cognitive Assessment test, the National Adult Reading Test, the Trail Making Test and the Iowa Gambling Task (IGT). RESULTS: Thirty-seven patients with AUD chose the RPP while 30 followed a HRP. The AUD group performed worse than controls on the IGT. The RPP group had significantly lower performance than both HRP and control groups (these later groups being not statistically different). No correlation was observed between the available clinical, cognitive and intellectual measures. CONCLUSION: This study confirms that the decision-making process of patients with an alcohol use disorder is impaired. However, the 2 groups differ on the IGT scores, despite comparable clinical and cognitive profiles. The patients\u27 decision-making abilities could be a useful guide when developing therapeutic programs

Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B)

Background The superiority of a chemotherapy with doxorubicin, cyclophosphamide, vindesine, bleomycin and prednisone (ACVBP) in comparison with cyclophosphamide, doxorubicin, vincristin and prednisone plus radiotherapy for young patients with localized diffuse large B-cell lymphoma (DLBCL) was previously demonstrated. We report the results of a trial which evaluates the role of rituximab combined with ACVBP (R-ACVBP) in these patients. Patients and methods Untreated patients younger than 66 years with stage I or II DLBCL and no adverse prognostic factors of the age-adjusted International Prognostic Index were randomly assigned to receive three cycles of ACVBP plus sequential consolidation with or without the addition of four infusions of rituximab. Results A total of 223 patients were randomly allocated to the study, 110 in the R-ACVBP group and 113 in the ACVBP group. After a median follow-up of 43 months, our 3-year estimate of event-free survival was 93% in the R-ACVBP group and 82% in the ACVBP group (P = 0.0487). Three-year estimate of progression-free survival was increased in the R-ACVBP group (95% versus 83%, P = 0.0205). Overall survival did not differ between the two groups with a 3-year estimates of 98% and 97%, respectively (P = 0.686). Conclusion In young patients with low-risk localized DLBCL, rituximab combined with three cycles of ACVBP plus consolidation is significantly superior to ACVBP plus consolidation alon

Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study

Background Diffuse large B-cell lymphomas (DLBCLs) arising in specific extranodal sites have peculiar clinicopathologic features. Patients and methods We analyzed a cohort of 187 primary Waldeyer's ring (WR) DLBCLs retrieved from GELA protocols using anthracyclin-based polychemotherapy. Results Most patients (92%) had stage I-II disease. A germinal center B-cell-like (GCB) immunophenotype was observed in 61%, and BCL2 expression in 55%, of WR DLBCLs. BCL2, BCL6, IRF4 and MYC breakpoints were observed in, respectively, 3 of 42 (7%), 9 of 36 (25%), 2 of 26 (8%) and 4 of 40 (10%) contributive cases. A variable follicular pattern was evidenced in 30 of 68 (44%) large biopsy specimens. The 5-year progression-free survival (PFS) and the overall survival (OS) of 153 WR DLBCL patients with survival information were 69.5% and 77.8%, respectively. The GCB immunophenotype correlated with a better OS (P=0.0015), while BCL2 expression predicted a worse OS (P=0.037), an effect overcome by the GCB/non-GCB classification. Compared with matched nodal DLBCLs, WR DLBCLs with no age-adjusted international prognostic index factor disclosed a better 5-year PFS rate (77.5% versus 70.7%; P=0.03). Conclusions WR DLBCLs display distinct clinicopathologic features compared with conventional DLBCLs, with usual localized-stage disease, common follicular features and a high frequency of GCB immunophenotype contrasting with a low rate of BCL2 rearrangements. In addition, they seem to be associated with a better outcome than their nodal counterpar

Results of the BiPo-1 prototype for radiopurity measurements for the SuperNEMO double beta decay source foils

The development of BiPo detectors is dedicated to the measurement of extremely high radiopurity in $^{208}$Tl and $^{214}$Bi for the SuperNEMO double beta decay source foils. A modular prototype, called BiPo-1, with 0.8 $m^2$ of sensitive surface area, has been running in the Modane Underground Laboratory since February, 2008. The goal of BiPo-1 is to measure the different components of the background and in particular the surface radiopurity of the plastic scintillators that make up the detector. The first phase of data collection has been dedicated to the measurement of the radiopurity in $^{208}$Tl. After more than one year of background measurement, a surface activity of the scintillators of $\mathcal{A}$($^{208}$Tl) $=$ 1.5 $\mu$Bq/m$^2$ is reported here. Given this level of background, a larger BiPo detector having 12 m$^2$ of active surface area, is able to qualify the radiopurity of the SuperNEMO selenium double beta decay foils with the required sensitivity of $\mathcal{A}$($^{208}$Tl) $<$ 2 $\mu$Bq/kg (90% C.L.) with a six month measurement.Comment: 24 pages, submitted to N.I.M.

Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B).

Background The superiority of a chemotherapy with doxorubicin, cyclophosphamide, vindesine, bleomycin and prednisone (ACVBP) in comparison with cyclophosphamide, doxorubicin, vincristin and prednisone plus radiotherapy for young patients with localized diffuse large B-cell lymphoma (DLBCL) was previously demonstrated. We report the results of a trial which evaluates the role of rituximab combined with ACVBP (R-ACVBP) in these patients. Patients and methods Untreated patients younger than 66 years with stage I or II DLBCL and no adverse prognostic factors of the age-adjusted International Prognostic Index were randomly assigned to receive three cycles of ACVBP plus sequential consolidation with or without the addition of four infusions of rituximab. Results A total of 223 patients were randomly allocated to the study, 110 in the R-ACVBP group and 113 in the ACVBP group. After a median follow-up of 43 months, our 3-year estimate of event-free survival was 93% in the R-ACVBP group and 82% in the ACVBP group (P = 0.0487). Three-year estimate of progression-free survival was increased in the R-ACVBP group (95% versus 83%, P = 0.0205). Overall survival did not differ between the two groups with a 3-year estimates of 98% and 97%, respectively (P = 0.686). Conclusion In young patients with low-risk localized DLBCL, rituximab combined with three cycles of ACVBP plus consolidation is significantly superior to ACVBP plus consolidation alone

A Modern Mode of Activation for Nucleic Acid Enzymes

Through evolution, enzymes have developed subtle modes of activation in order to ensure the sufficiently high substrate specificity required by modern cellular metabolism. One of these modes is the use of a target-dependent module (i.e. a docking domain) such as those found in signalling kinases. Upon the binding of the target to a docking domain, the substrate is positioned within the catalytic site. The prodomain acts as a target-dependent module switching the kinase from an off state to an on state. As compared to the allosteric mode of activation, there is no need for the presence of a third partner. None of the ribozymes discovered to date have such a mode of activation, nor does any other known RNA. Starting from a specific on/off adaptor for the hepatitis delta virus ribozyme, that differs but has a mechanism reminiscent of this signalling kinase, we have adapted this mode of activation, using the techniques of molecular engineering, to both catalytic RNAs and DNAs exhibiting various activities. Specifically, we adapted three cleaving ribozymes (hepatitis delta virus, hammerhead and hairpin ribozymes), a cleaving 10-23 deoxyribozyme, a ligating hairpin ribozyme and an artificially selected capping ribozyme. In each case, there was a significant gain in terms of substrate specificity. Even if this mode of control is unreported for natural catalytic nucleic acids, its use needs not be limited to proteinous enzymes. We suggest that the complexity of the modern cellular metabolism might have been an important selective pressure in this evolutionary process

New Trends in Beverage Packaging Systems: A Review

New trends in beverage packaging are focusing on the structure modification of packaging materials and the development of new active and/or intelligent systems, which can interact with the product or its environment, improving the conservation of beverages, such as wine, juice or beer, customer acceptability, and food security. In this paper, the main nutritional and organoleptic degradation processes of beverages, such as oxidative degradation or changes in the aromatic profiles, which influence their color and volatile composition are summarized. Finally, the description of the current situation of beverage packaging materials and new possible, emerging strategies to overcome some of the pending issues are discussed

The Variability of the Harlequin Mouse Phenotype Resembles that of Human Mitochondrial-Complex I-Deficiency Syndromes

Background: Despite the considerable progress made in understanding the molecular bases of mitochondrial diseases, no effective treatments have been developed to date. Faithful animal models would be extremely helpful for designing such treatments. We showed previously that the Harlequin mouse phenotype was due to a specific mitochondrial complex I deficiency resulting from the loss of the Apoptosis Inducing Factor (Aif) protein. Methodology/Principal Findings: Here, we conducted a detailed evaluation of the Harlequin mouse phenotype, including the biochemical abnormalities in various tissues. We observed highly variable disease expression considering both severity and time course progression. In each tissue, abnormalities correlated with the residual amount of the respiratory chain complex I 20 kDa subunit, rather than with residual Aif protein. Antioxidant enzyme activities were normal except in skeletal muscle, where they were moderately elevated. Conclusions/Significance: Thus, the Harlequin mouse phenotype appears to result from mitochondrial respiratory chain complex I deficiency. Its features resemble those of human complex I deficiency syndromes. The Harlequin mouse hold